Phoxilium 1.2 mmol/l phosphate Solution for haemodialysis/haemofiltration Ireland - English - HPRA (Health Products Regulatory Authority)

phoxilium 1.2 mmol/l phosphate solution for haemodialysis/haemofiltration

gambro lundia ab - calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride ph.eur.; sodium hydrogen carbonate; potassium chloride; disodium phosphate dihydrate - solution for haemodialysis/haemofiltration - 1.2 mmol/l - hemofiltrates

POTASSIUM CHLORIDE solution United States - English - NLM (National Library of Medicine)

potassium chloride solution

atlantic biologicals corps - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - potassium chloride 20 meq in 15 ml - potassium chloride is indicated for the treatment and prophylaxis of hypokalemia in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. potassium chloride is contraindicated in patients on potassium sparing diuretics pregnancy category c animal reproduction studies have not been conducted with potassium chloride. it is unlikely that potassium supplementation that does not lead to hyperkalemia would have an adverse effect on the fetus or would affect reproductive capacity. the normal potassium ion content of human milk is about 13 meq per liter. since oral potassium becomes part of the body potassium pool, so long as body potassium is not excessive, the contribution of potassium chloride supplementation should have little or no effect on the level in human milk. the safety and effectiveness of potassium chloride have been demonstrated in children with diarrhea and malnutrition from birth to18 years. clinical studies of potassium chloride did not include s

Phoxilium 1.2 mmol/l phosphate Solution for haemodialysis/haemofiltration Ireland - English - HPRA (Health Products Regulatory Authority)

phoxilium 1.2 mmol/l phosphate solution for haemodialysis/haemofiltration

baxter holding b.v. - calcium chloride dihydrate; magnesium chloride hexahydrate; sodium chloride ph.eur.; sodium hydrogen carbonate; potassium chloride; disodium phosphate dihydrate - solution for haemodialysis/haemofiltration - 1.2 mmol/l - hemofiltrates

Prismasol 2 mmol/l Potassium solution for haemodialysis/haemofiltration Ireland - English - HPRA (Health Products Regulatory Authority)

prismasol 2 mmol/l potassium solution for haemodialysis/haemofiltration

gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride ph.eur.; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; lactate; hydrogen carbonate; chloride; potassium; glucose - solution for haemodialysis/haemofiltration - 2 millimole(s)/litre - hemofiltrates

Prismasol 4 mmol/l Potassium solution for haemodialysis/haemofiltration Ireland - English - HPRA (Health Products Regulatory Authority)

prismasol 4 mmol/l potassium solution for haemodialysis/haemofiltration

gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactase; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 4 millimole(s)/litre - hemofiltrates

Prismasol 4 mmol/l Potassium solution for haemodialysis/haemofiltration Ireland - English - HPRA (Health Products Regulatory Authority)

prismasol 4 mmol/l potassium solution for haemodialysis/haemofiltration

gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactate; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 4 millimole(s)/litre - hemofiltrates

Prismasol 2 mmol/l Potassium solution for haemodialysis/haemofiltration Ireland - English - HPRA (Health Products Regulatory Authority)

prismasol 2 mmol/l potassium solution for haemodialysis/haemofiltration

gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactate; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 2 millimole(s)/litre - hemofiltrates

potassium chloride- potassium chloride capsule, extended release United States - English - NLM (National Library of Medicine)

potassium chloride- potassium chloride capsule, extended release

ethex - potassium chloride (unii: 660yq98i10) (potassium ion - unii:295o53k152) - capsule, extended release - 750 mg - because of reports of intestinal and gastric ulceration and bleeding with controlled-release potassium chloride preparations, these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations or for patients in whom there is a problem of compliance with these preparations. - for the treatment of patients with hypokalemia, with or without metabolic alkalosis, in digitalis intoxications, and in patients with hypokalemic familial periodic paralysis. if hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. - for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias, hepatic cirrhosis with ascites, states of aldosterone excess with normal renal function, potassium-losing nephropathy, and certain diarrhe

POTASSIUM CHLORIDE tablet, film coated, extended release United States - English - NLM (National Library of Medicine)

potassium chloride tablet, film coated, extended release

tya pharmaceuticals - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium chloride 750 mg - because of reports of intestinal and gastric ulceration and bleeding with controlled-release potassium chloride preparations, these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations, or for patients with whom there is a problem of compliance with these preparations. - for the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. if hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. - for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias. the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patient

Potassium chloride 20% (potassium 13.3mmol/5ml) solution for infusion 5ml ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 20% (potassium 13.3mmol/5ml) solution for infusion 5ml ampoules

potassium 13.3mmol/5ml) solution for infusion 5ml ampoules (martindale pharmaceuticals ltd - potassium chloride - solution for infusion - 200mg/1ml